Models for prediction of mortality from cirrhosis with special reference to artificial neural network: A critical review

Hepatology International

Volumn 2, Issue 1, 2008, Pages 31-38

  Ghoshal, Uday Chand ^a   Das, Ananya ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b MAYO CLINIC   (United States)

Author keywords

Child Pugh score; Liver disease; Liver transplantation; MELD score; Neural network; Outcome prediction

Indexed keywords

ARTIFICIAL NEURAL NETWORK; ASCITES; BACTERIAL PERITONITIS; BRAIN DISEASE; CHRONIC LIVER DISEASE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MEDICAL DECISION MAKING; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 69749126033     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-007-9026-1     Document Type: Review

References (58)

1. Perkins J. Liver transplantation worldwide. Liver Transpl 2006;12:159-62
2. Chaib E, Massad E. Liver transplantation: Waiting list dynamics in the state of Sao Paulo, Brazil. Transplant Proc 2005;37:4329-30
3. Institute of Medicine. Analysis of waiting times. In: Committee on organ transplantation: Assessing current policies and the potential impact of the DHHS final rule. Washington: National Academy Press. 1999. p. 57-78
4. Hunt D, Haynes R, Hanna S, Smith K. Effects of computer-based decision support systems on physician performance and patient outcomes. JAMA 1998;280:1339-46
5. Blumenthal D. The future of quality measurement and management in a transforming health care system. JAMA 1997;278:1622-5
6. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-4
7. Forman L, Lucey M. Predicting the prognosis of chronic liver disease: An evolution from Child to MELD. Hepatology 2001;33:473-5
8. Ho YP, Chen YC, Yang C, Lien JM, Chu YY, Fang JT, et al. Outcome prediction for critically ill cirrhotic patients: A comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Med 2004;19:105-10
9. Nagashima I, Takada T, Okinaga K, Nagawa H A. scoring system for the assessment of the risk of mortality after partial hepatectomy in patients with chronic liver dysfunction. J Hepatobiliary Pancreat Surg 2005;12:44-8
10. Serra MA, Puchades MJ, Rodriguez F, Escudero A, del Olmo JA, Wassel AH, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scand J Gastroenterol 2004;39:1149-53
11. Yoneyama K, Taniguchi H, Kiuchi Y, Shibata M, Mitamura K. Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma. Scand J Gastroenterol 2004;39:1272-9
12. Zauner CA, Apsner RC, Kranz A, Kramer L, Madl C, Schneider B, et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: A comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med 1996;22:559-63
13. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12:65-71
14. Arabi Y, Ahmed QA, Haddad S, Aljumah A, Al-Shimemeri A. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 2004;16:333-9
15. Korner T, Kropf J, Kosche B, Kristahl H, Jaspersen D, Gressner AM. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol 2003;39:947-53
16. Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 1998;30:276-82
17. Ripoll C, Banares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005;42:793-801
18. Tsuji Y, Koga S, Ibayashi H, Nose Y, Akazawa K. Prediction of the prognosis of liver cirrhosis in Japanese using Cox's proportional hazard model. Gastroenterol Jpn 1987;22:599-606
19. Sumskiene J, Kupcinskas L, Pundzius J, Sumskas L. Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas) 2005;41:39-46
20. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9
21. Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 1989;24:999-1006
22. Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Fernandez-Banares F, Esteve M, Planas R, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993;88:382-7
23. Gatta A, Merkel C, Amodio P, Bellon S, Bellumat A, Bolognesi M, et al. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: A multicenter study. Am J Gastroenterol 1994;89:1528-36
24. Adler M, Verset D, Bouhdid H, Bourgeois N, Gulbis B, Le Moine O, et al. Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score. J Hepatol 1997;26:642-9
25. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-5
26. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138-44
27. Kamath PS, Kim WR. The Model for End-stage Liver Disease (MELD). Hepatology 2007;45:797-805
28. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36:494-500
29. Buenadicha AL, Martin LG, Martin EE, Pajares AD, Perez AM, Seral CC, et al. Assessment of short-term survival after liver transplant by the Model for End-stage Liver Disease. Transplant Proc 2005;37:3881-3
30. Oton-Nieto E, Barcena-Marugan R, Carrera-Alonso E, Blesa-Radigales C, Garcia-Gonzalez M, Nuno J, et al. Variability of MELD score during the year before liver transplantation. Transplant Proc 2005;37:3887-8
31. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70
32. Schrander-van der Meer AM, Vogten AJ. Estimation of survival probability in cirrhotics. Evaluation of a computer model applicable for decision-making. Neth J Med 1992;40:183-9
33. van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, et al. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation. Hepatogastroenterology 1997;44:732-43
34. Sheth M, Riggs M, Patel T. Utility of the Mayo End-stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:2
35. Banerjee R, Das A, Ghoshal UC, Sinha M. Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol 2003;18:1054-60
36. Child III CG, Turcotte JG. Surgery and portal hypertension. In: Child III CG, (editor). The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50
37. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15
38. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the Model for End-stage Liver Disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-61
39. Cross S, Harrison R, Kennedy R. Introduction to neural networks. Lancet 1995;346:1075-79
40. Miller GA. The magical number seven plus or minus two: Some limits on our capacity for processing information. Psychol Rev 1956;63:81-97
41. Forsstrom JJ, Dalton KJ. Artificial neural networks for decision support in clinical medicine. Ann Med 1995;27:509-17
42. Dayhoff JE, DeLeo JM. Artificial neural networks: Opening the black box. Cancer 2001;91:1615-35
43. Rodvold DM, McLeod DG, Brandt JM, Snow PB, Murphy GP. Introduction to artificial neural networks for physicians: Taking the lid off the black box. Prostate 2001;46:39-44
44. Boutsinas B, Vrahatis M. Artificial nonmonotonic neural networks. Artificial Intelligence 2001;132:1-38
45. Lisboa P. A review of evidence of health benefit from artificial neural networks in medical intervention. Neurol Network 2002;15:11-39
46. Ramesh AN, Kambhampati C, Monson JR, Drew PJ. Artificial intelligence in medicine. Ann R Coll Surg Engl 2004;86:334-8
47. Sharpe PK, Caleb P. Artificial neural networks within medical decision support systems. Scand J Clin Lab Invest Suppl 1994;219:3-11
48. Tafeit E, Reibnegger G. Artificial neural networks in laboratory medicine and medical outcome prediction. Clin Chem Lab Med 1999;37:845-53
49. Winkler DA. Neural networks as robust tools in drug lead discovery and development. Mol Biotechnol 2004;27:139-68
50. Dytch HE, Wied GL. Artificial neural networks and their use in quantitative pathology. Anal Quant Cytol Histol 1990;12:379-93
51. Khan ZH, Mohapatra SK, Khodiar PK, Ragu Kumar SN. Artificial neural network and medicine. Indian J Physiol Pharmacol 1998;42:321-42
52. Itchhaporia D, Snow PB, Almassy RJ, Oetgen WJ. Artificial neural networks: Current status in cardiovascular medicine. J Am Coll Cardiol 1996;28:515-21
53. Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L, et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007;56:253-8
54. Lapuerta P, Rajan S, Bonacini M. Neural networks as predictors of outcomes in alcoholic patients with severe liver disease. Hepatology 1997;25:302-6
55. Plumb AP, Rowe RC, York P, Brown M. Optimisation of the predictive ability of artificial neural network (ANN) models: A comparison of three ANN programs and four classes of training algorithm. Eur J Pharm Sci 2005;25:395-405
56. Chen Y, Jiao T, McCall TW, Baichwal AR, Meyer MC. Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets. Pharm Dev Technol 2002;7:373-9
57. Wyatt J. Nervous about artificial neural networks?. Lancet 1995;346:1175-7
58. Garibaldi R. Computers and the quality of care - A clinician's perspective. New Engl J Med 1998;338:259-60